Nuvation Bio, Inc. (NUVB)
7.84
-0.16
(-2.00%)
USD |
NYSE |
Dec 10, 16:00
7.79
-0.05
(-0.64%)
Pre-Market: 09:08
Nuvation Bio EPS Diluted (Quarterly): -0.163 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Pfizer Inc. | 0.6197 |
| KalVista Pharmaceuticals, Inc. | -0.9183 |
| Rapid Micro Biosystems, Inc. | -0.2559 |
| ARS Pharmaceuticals, Inc. | -0.5177 |
| CEL-SCI Corp. | -1.365 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -55.79M |
| Revenue (Quarterly) | 13.12M |
| Total Expenses (Quarterly) | 68.91M |
| Enterprise Value | 2.347B |
| Gross Profit Margin (Quarterly) | 70.40% |
| Profit Margin (Quarterly) | -425.2% |
| Earnings Yield | -8.17% |
| Normalized Earnings Yield | -8.143 |